Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
parkinson's neuritis neuralgia myasthenia gravis lactic acidosis ataxia seizure tinnitus migraine hypotoniaYour Article Summary
See Latest ArticlesAZT 5-triphosphate nanoformulation suppresses human immunodeficiency virus type 1 replication in peripheral blood mononuclear cells
Journal of Neurovirology, 07/07/09
Saiyed ZM et al. - Inefficient cellular phosphorylation of nucleoside and nucleotide analog reverse transcriptase inhibitors (NRTIs) to their active nucleoside 5'-triphosphate (NTPs) form is one of the limitations for human immunodeficiency virus (HIV) therapy. The developed MP-AZTTP nanoformulation can be used for targeting active NRTIs to the brain by application of an external magnetic force and thereby eliminate the brain HIV reservoir and help to treat NeuroAIDS.
Today in CNS Infectious Disease...keeping you current
Receive free subspecialty "5-minute updates" via email
Rabies viral encephalitis – clinical determinants in diagnosis with special reference to paralytic form
Journal of Neurology, Neurosurgery, and Psychiatry , 12/18/09
Reactivation and centripetal spread of herpes simplex virus complicating acoustic neuroma resection
Surgical Neurology, 12/18/09
Tick-borne encephalitis in children: an update on epidemiology and diagnosis
Expert Review of Anti-infective Therapy, 12/18/09
Sponsor
Article Search
Sponsor
Sponsor